Labcorp Holdings Deferred Revenue decreased by 7.7% to $405.20M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 4.4%, from $388.30M to $405.20M. Over 5 years (FY 2020 to FY 2025), Deferred Revenue shows a downward trend with a -2.8% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase is generally positive, signaling strong future demand and cash collection, while a decrease indicates the fulfillment of obligations.
This represents payments received from customers for goods or services that have not yet been delivered or performed. It...
Common in subscription and long-term contract businesses; highly indicative of future revenue visibility.
deferred_revenue_current| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $5.62B | $5.41B | $558.50M | $6.07B | $6.13B | $6.01B | $310.60M | $4.72B | $349.70M | $360.80M | $421.70M | $377.50M | $388.30M | $403.10M | $392.20M | $388.30M | $398.00M | $391.60M | $439.10M | $405.20M |
| QoQ Change | — | -3.6% | -89.7% | +986.8% | +1.0% | -2.1% | -94.8% | >999% | -92.6% | +3.2% | +16.9% | -10.5% | +2.9% | +3.8% | -2.7% | -1.0% | +2.5% | -1.6% | +12.1% | -7.7% |
| YoY Change | — | — | — | — | +9.2% | +11.0% | -44.4% | -22.2% | -94.3% | -94.0% | +35.8% | -92.0% | +11.0% | +11.7% | -7.0% | +2.9% | +2.5% | -2.9% | +12.0% | +4.4% |